|Articles|October 10, 2011

Supplements and Featured Publications

  • The Case for Early Initiation of Monotherapies and Delayed Dopaminergic Therapy in Parkinson's Disea
  • Volume 17
  • Issue 12 Suppl

The Case for Early Initiation of Monotherapies and Delayed Dopaminergic Therapy in Parkinson's Disease

After reading "The Case for Early Initiation of Monotherapies and Delayed Dopaminergic Therapy in Parkinson’s Disease,” participants must complete the online evaluation form and achieve a passing score of 70% or higher on the online posttest. Upon submission of the completed evaluation and posttest, participants may print their statement of credit.

TAKE PHYSICIAN CME TEST

TAKE PHARMACIST CE TEST

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo